NCT05897970 (PREDICT-ACLv2) is a clinical trial of Return-to-sport (RTS) follow-up in ACL Injury, sponsored by University Hospital, Caen.

Who is sponsoring NCT05897970?

NCT05897970 is sponsored by University Hospital, Caen.

What drugs are being tested in NCT05897970?

Interventions in NCT05897970: Return-to-sport (RTS) follow-up.

What condition does NCT05897970 study?

NCT05897970 studies ACL Injury, Knee Injuries, Muscle Weakness.

Is NCT05897970 still recruiting?

NCT05897970 is currently completed. Last updated 26 March 2025.

Last reviewed 2025-03-26 · How we verify

NCT05897970: PREDICT-ACLv2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Association Between 4-Month Isokinetic Testing Measures and Second Knee Injuries After Primary Anterior Cruciate Ligament Reconstruction

Completed Last updated 26 March 2025

What this trial tests

trial testing Return-to-sport (RTS) follow-up in ACL Injury in 150 participants. Completed in 1 May 2023.

Timeline

1 May 2021

Primary endpoint
1 May 2021

1 May 2023

Quick facts

Lead sponsor	University Hospital, Caen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 May 2021
Primary completion	1 May 2021
Estimated completion	1 May 2023
Sites	1 location across France

Drugs / interventions tested

Return-to-sport (RTS) follow-up

Conditions studied

ACL Injury — all drugs for ACL Injury →
Knee Injuries — all drugs for Knee Injuries →
Muscle Weakness — all drugs for Muscle Weakness →

Sponsor

University Hospital, Caen

Who can join

Adults 16 to 55, any sex, with ACL Injury or Knee Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anterior cruciate ligament (ACL) is a frequent and disabling injury in athletes. Most of the time, ACL reconstruction (ACLR) is consider for regaining function and returning to preinjury sports while reducing the risk of secondary injuries. However, the risk of secondary severe knee injury is increased after ACLR, especially in athletes returning to strenuous activities. If strength symmetry is considered as an important factor in the Return-to-sport (RTS) decision, there is conflicting data about the association between strength symmetry and the risk of second knee injury after ACLR. The main objective of this study was to test if knee muscles strength symmetry at 4 months was associated with the psychological readiness and incidence of subsequent severe injury of both knees at a minimum 2 years follow-up after ACL-R.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
NCT06194682 — Anterior Cruciate Ligament Study · recruiting

Other University Hospital, Caen trials

Trials by the same sponsor.

NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05897970 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
Last refreshed: 26 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05897970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing